tetraethylammonium has been researched along with Cerebral Infarction, Middle Cerebral Artery in 2 studies
Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Honsa, P | 1 |
| Pivonkova, H | 1 |
| Anderova, M | 1 |
| Wei, L | 1 |
| Yu, SP | 1 |
| Gottron, F | 1 |
| Snider, BJ | 1 |
| Zipfel, GJ | 1 |
| Choi, DW | 1 |
2 other studies available for tetraethylammonium and Cerebral Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Focal cerebral ischemia induces the neurogenic potential of mouse Dach1-expressing cells in the dorsal part of the lateral ventricles.
Topics: 4-Aminopyridine; Adult Stem Cells; Animals; Cell Count; Cell Differentiation; Disease Models, Animal | 2013 |
Potassium channel blockers attenuate hypoxia- and ischemia-induced neuronal death in vitro and in vivo.
Topics: Animals; Apoptosis; Brain Ischemia; Calcium; Calcium Channels; Calcium Signaling; Carotid Artery, Co | 2003 |